The disclosure of the 2021 annual report is coming to an end, and the dividend situation of listed companies on the science and innovation board has also surfaced.
As of 8:30 p.m. on April 28, more than 380 Sci-tech Innovation Board companies have disclosed their annual performance in 2021, of which 302 companies have simultaneously issued cash dividend plans, with a total annual dividend of more than 28 billion yuan. At the same time, nearly 30 Sci-tech Innovation Board companies have launched stock transfer schemes while implementing cash dividends.
Market participants said that the dividend distribution is not only favored by the market and investors, but also shows the optimistic expectation of listed companies for future profits and their confidence in cash flow management. The implementation of stock transfer is conducive to reducing the investment threshold, improving stock liquidity and stimulating market vitality.
science and Innovation Board plans to pay more than 28 billion yuan of dividends in 2021
As of 8:30 p.m. on April 28, more than 380 Sci-tech Innovation Board companies have disclosed their annual performance in 2021, of which 302 companies have simultaneously issued cash dividend plans, with a total annual dividend of more than 28 billion yuan.
In terms of dividend per share, the dividend per share of more than 30 Kechuang board companies exceeds 1 yuan and that of more than 10 companies exceeds 2 yuan. Among them, Jiangsu Bioperfectus Technologies Co.Ltd(688399) , Zhejiang Orient Gene Biotech Co.Ltd(688298) , Beijing Hotgen Biotech Co.Ltd(688068) ranked among the top three, and the cash distribution per share reached 10 yuan, 6.18 yuan and 5 yuan respectively.
China Securities News · China Securities Taurus reporter noted that the above three companies are in vitro diagnostic reagent enterprises. The company's main businesses are R & D and production of nucleic acid detection, antigen detection and other products. The company's performance has increased significantly in recent years.
The total annual dividends of companies exceeded .
Among them, China Railway Signal & Communication Corporation Limited(688009) continues the tradition of high dividend, and the total annual cash dividends in the last three years have reached 2.1 billion yuan, 2.1 billion yuan and 1.8 billion yuan respectively. In 2021, China Railway Signal & Communication Corporation Limited(688009) plans to distribute a cash dividend of 1.7 yuan (including tax) for every 10 shares.
Xinjiang Daqo New Energy Co.Ltd(688303) listed in 2021 started a large amount of dividends in the first year of listing. It is planned to pay 6 yuan out of 10, and the total amount of cash dividends will reach 1.155 billion yuan. The confidence of high dividends just listed also comes from the strong performance growth of the company. In 2021, Xinjiang Daqo New Energy Co.Ltd(688303) achieved an operating revenue of 10.832 billion yuan, a year-on-year increase of 132.23%, and a net profit attributable to the parent company of 5.724 billion yuan, a year-on-year increase of 448.56%. In the first quarter of 2022, Xinjiang Daqo New Energy Co.Ltd(688303) operating revenue and net profit attributable to parent company increased by 389.28% and 640.85% respectively.
Insiders said that cash dividend is an important form of return to investors, which can enable investors to generate actual cash income, increase investors' capital liquidity, and reallocate resources on this basis. At the same time, cash dividends should be based on objective profits and sufficient cash flow, which can better prove that listed companies have stable profitability.
For a long time, the CSRC and the exchange have been committed to advocating listed companies to establish a sustained and stable cash dividend policy. In April this year, the CSRC and other departments jointly issued a document to support listed companies to increase the proportion of cash dividends in profit distribution in combination with the industry characteristics, development stage and profitability of the company, share development Dividends with investors and enhance the sense of gain of investors.
nearly 30 companies have launched transfer schemes
As of 8:30 p.m. on April 28, nearly 30 Sci-tech Innovation Board companies have launched stock transfer schemes while implementing cash dividends. Among them, Beijing Hotgen Biotech Co.Ltd(688068) transfer ratio is 4.8 shares per 10 shares, ranking first. According to the data, benefiting from the rapid growth of covid-19 antigen rapid detection products, the foreign trade business increased by 946% in Beijing Hotgen Biotech Co.Ltd(688068) 2021, and the net profit attributable to the parent company increased by 1850%, becoming the enterprise with the highest growth rate of net profit on the science and Innovation Board at present.
It is worth noting that at present, Hemai shares, which has the highest share price on the science and innovation board, also launched a profit distribution scheme of "cash dividend + conversion to increase" when the annual report was released. The company plans to distribute cash dividend of 30 yuan (including tax) for every 10 shares, and increase 4 shares for every 10 shares to all shareholders with capital reserve.
The latest closing price shows that Hemai shares are reported at 608.05 yuan / share, which is second only to Kweichow Moutai Co.Ltd(600519) . In the issuance stage, the company was known as "the most expensive new share of a shares", and the issuance price was as high as 557.80 yuan / share, which deterred and abandoned many investors who hit the new shares. However, the company's share price exceeded 800 yuan / share after listing. Recently, A-share fluctuated, and the latest share price of Hemai shares still rose by 9% compared with the issue price. In the view of market participants, this is mainly due to the high prosperity of the company's photovoltaic industry and its own brilliant performance. In 2021, the operating revenue and net profit attributable to the parent company of Hemai shares increased by 61% and 94% respectively.
From the perspective of share capital scale, the total share capital of Hemai shares is 40 million shares, and the circulating share capital is only 8.8 million shares. The excessively high share price is not conducive to the liquidity of shares in the long run. After the increase, the total share capital of the company will increase to 56 million shares, which will activate the trading activity of the secondary market to a certain extent and attract more capital attention.
A senior market person pointed out that the overall share capital of Kechuang board company is small, the share price is high, and the competitive trading of Kechuang board is 200 shares, and the high share price leads to high transaction costs. At present, nearly 60% of the companies on the sci-tech innovation board have less than 50 million freely circulating shares, and the share prices of 53 Sci-tech Innovation Board companies exceed 100 yuan, accounting for 44% of the "100 yuan shares" in the A-share market. The rational implementation of stock transfer is conducive to reducing stock prices, improving stock liquidity and capital attraction, and stimulating market vitality. It is not only a necessary means for listed companies to manage liquidity, but also reflects the voice of most investors.
60% of the company's net profit in the first quarter increased
As of April 28, the number of listed companies on the science and innovation board has reached 418. According to the disclosed annual report and performance express data, in 2021, the overall operating revenue of the science and Innovation Board increased by 37% year-on-year, and the net profit attributable to the parent increased by 76% year-on-year, which has gradually become the main force to activate the driving force of innovation.
At the same time, the first quarterly report of the science and Innovation Board also showed a sustained and steady growth trend. As of 8:30 p.m. on April 28, more than 320 Sci-tech Innovation Board companies have disclosed the performance data of the first quarter of 2022. The overall operating revenue has increased by 49% year-on-year, the net profit attributable to the parent company has increased by 83% year-on-year, and 60% of the company's net profit has increased.
Among them, a number of leaders in subdivided industries took the lead in handing over bright transcripts. For example, polysilicon leader Xinjiang Daqo New Energy Co.Ltd(688303) achieved a revenue of 8.129 billion yuan in the first quarter, a year-on-year increase of 389%; The net profit attributable to the parent company was 4.312 billion yuan, a year-on-year increase of 641%. In the first quarter, the materials for monocrystalline silicon wafers produced by the company accounted for more than 97%, realizing the batch sales of n-type high-purity silicon materials, which is at the leading level in the industry.
IDM mode power semiconductor leader China Resources Microelectronics Limited(688396) achieved an operating revenue of 2.514 billion yuan in the first quarter, a year-on-year increase of 23%; The net profit attributable to the parent company was 619 million yuan, a year-on-year increase of 55%, and the gross profit margin increased by 5.04 percentage points year-on-year.
Insiders said that the company's high growth logic remains unchanged, its fundamentals are stable and good, and continues to make progress in technological breakthroughs, showing the investment value and growth value of the science and innovation board.
